➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Colorcon
Harvard Business School
Dow
Johnson and Johnson

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Eperisone

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Eperisone?

Eperisone is an investigational drug.

There have been 12 clinical trials for Eperisone. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2011.

The most common disease conditions in clinical trials are Back Pain, Spasm, and Low Back Pain. The leading clinical trial sponsors are Tanta University, Eisai Co., Ltd., and Daewon Pharmaceutical Co., Ltd.

There are one hundred and sixty-three US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Eperisone
TitleSponsorPhase
Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back PainLudwig-Maximilians - University of MunichN/A
Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back PainFirst Affiliated Hospital of Zhejiang UniversityN/A
Cyclobenzaprine in Muscle Cramps With Liver CirrhosisTanta UniversityPhase 3

See all Eperisone clinical trials

Clinical Trial Summary for Eperisone

Top disease conditions for Eperisone
Top clinical trial sponsors for Eperisone

See all Eperisone clinical trials

US Patents for Eperisone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Eperisone   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Eperisone   Start Trial Animal treatments NEW MARKET PHARMACEUTICALS, LLC (Princeton, NJ)   Start Trial
Eperisone   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Eperisone   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Eperisone   Start Trial Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Eperisone   Start Trial Methods of treating or preventing multiple sclerosis Toray Industries, Inc. (JP)   Start Trial
Eperisone   Start Trial Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Eperisone

Drugname Country Document Number Estimated Expiration Related US Patent
Eperisone Canada CA2961033 2034-09-11   Start Trial
Eperisone European Patent Office EP3192791 2034-09-11   Start Trial
Eperisone Japan JPWO2016039408 2034-09-11   Start Trial
Eperisone World Intellectual Property Organization (WIPO) WO2016039408 2034-09-11   Start Trial
Eperisone World Intellectual Property Organization (WIPO) WO2012106058 2031-01-31   Start Trial
Eperisone Argentina AR098909 2033-07-03   Start Trial
Eperisone European Patent Office EP3018126 2033-07-03   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Colorcon
Harvard Business School
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.